Related by context. All words. (Click for frequent words.) 62 Supplementary Appendix 60 Supplementary Table 59 Supplemental Schedule 58 Supplementary Figs 58 Fig. 2a 58 non GAAP Measures 58 Supplementary Fig 57 Non GAAP Measure 57 Fig. 2c 57 Fig. 1a 56 Supplementary Data 56 Fig. 2D 56 Fig. 1b 56 Fig. 3b 56 Fig. 1A 56 Fig. 3A 56 Supplemental Schedules 55 Supplemental Figure 55 Reconciliation Tables 55 τ 55 Fig. 3d 55 Figure 2a 55 Fig. 1D 54 Appendix B 54 Figure 1a 54 fig. S3 54 Appendix 4E 54 Fig. 2B 54 ε 54 Items Affecting Comparability 54 Cash Flow Statement 54 fig. S1 54 stoichiometry 54 Histopathologic 54 Dirac fermions 54 See Attachment 54 dI dV 54 Appendix 54 NON GAAP MEASURES 53 DOSAGE AND ADMINISTRATION 53 ellipsoids 53 Condensed Consolidated 53 Histologic 53 Non GAAP reconciliations 53 Supplemental Table 53 Fig. 53 Supplemental Non GAAP 53 Significant Accounting Policies 53 MDRD 53 γ 53 sigmoidal 53 Unaudited Reconciliation 53 Fig. 2b 53 Fig. 2C 53 Fig. 1c 53 condensed consolidated interim 52 fig. S2 52 Non GAAP Measures 52 Fig. 4A 52 Non IFRS 52 Longitudinal Section 52 Pearson correlation coefficient 52 anisotropy 52 η 52 radioligand 52 See Appendix 52 Non GAAP Measurements 52 Schematic diagram 52 interim unaudited consolidated 52 #.#-# [006] 52 CFR § #.# [002] 52 antiferromagnetic 52 entitled Caution Regarding 52 Accounting Policies 52 photoemission 52 Attachment 52 Rev. Proc 52 Schematic representation 52 Standardized Distributable Cash 52 Figure 3a 52 Recent Accounting Pronouncements 52 Measures Reconciliation 52 Managements Discussion 52 post perovskite 51 inelastic scattering 51 Figs. 51 nucleotide sequences 51 FIRST DATA CORPORATION 51 figs. 51 Figure 1C 51 MANAGEMENT DISCUSSION AND ANALYSIS 51 Summary Table 51 delocalized 51 Fig. 1C 51 shear modulus 51 Items affecting comparability 51 Annual Audited Consolidated 51 Mg Ca 51 FDG uptake 51 Explanatory Note 51 meV 51 ARPES 51 Appendix 5B 51 EDWARDS LIFESCIENCES CORPORATION 51 Fig. 3B 51 fig. S4 51 Unaudited Pro Forma 51 Interim Consolidated 51 Sensitivity Analysis 51 magnetization 51 tetragonal 51 #.#-# [005] 51 ν 51 Historical Pro Forma 51 FINANCIAL STATEMENTS 51 - -Crazyhorse 51 Figure 4a 51 Segmental 51 Non GAAP Reconciliations 51 Significant assay 51 μm diameter 51 quasiparticle 51 #ppm U 51 cytochrome 51 anisotropic 50 adsorption isotherms 50 CFR #.# c 50 Critical Accounting Policies 50 rostral 50 Unaudited Reconciliations 50 Segmented Results 50 SNe Ia 50 immunoreactivity 50 Fig. 3c 50 autocorrelation 50 φ 50 orbitals 50 hematoxylin eosin original 50 Annexures 50 - Non GAAP [031] 50 Pro Forma Results 50 Fig. 2A 50 accompanying unaudited consolidated 50 linear interpolation 50 SiO 2 50 κ 50 USC § #u 50 Explanatory Notes 50 heterogeneities 50 Figure 1b 50 Appendix 4D 50 coronal 50 Nb Ta 50 linewidth 50 Photometric 50 isotope fractionation 50 Fig. 1d 50 Condensed Statement 50 Eq. 50 DHC consolidated 50 X ray absorption spectroscopy 50 Figure 2C 50 Appendix Table 50 CONSOLIDATED FINANCIAL STATEMENTS 50 Fig. 4B 50 Distributable Cash 50 CdSe 50 Quantification 50 www.magsilver.com 50 θ 50 Descriptive statistics 50 Fig. 3a 50 hematoxylin 50 Consolidated Financial 50 Significant Transactions Affecting 50 electron density 50 Pricing Supplement 50 diffraction pattern 49 tabular reconciliation 49 excitation energies 49 #.#-# b [001] 49 petrographic 49 Non GAAP Reconciliation 49 § #.#-# [004] 49 SDS PAGE 49 Comparability 49 Significant Items Affecting 49 -Cedomir Jovanovic 49 ω 49 circular dichroism 49 branes 49 subparagraphs 49 serine 49 Morphological 49 paraffin embedded tissue 49 kyr 49 NON GAAP 49 Fig.1 49 kcal mol 49 Selected GAAP Measures 49 Brillouin zone 49 Sagittal 49 ref. 49 Fig. 4a 49 deoxy 49 Unaudited Condensed Consolidated 49 ρ 49 Fig. 1e 49 -Genereaux 49 fluorescence intensity 49 Macroscopic 49 Ordinary Dividends 49 triangular lattice 49 magnetic susceptibility 49 histopathologic 49 TDR TDT 49 Phylogenetic analysis 49 captioned Adjusted EBITDA 49 equilibration 49 quantum capacitance 49 Non Gaap 49 collinear 49 Comparative Figures 49 A.2 49 immunostaining 49 cuprate 49 Quantitative RT PCR 49 histologic findings 49 www.dundeereit.com 49 magnon 49 cuprates 49 Consolidated Cash Flows 49 subcellular localization 49 -John F. Biemeck 49 Saprolite mafic intrusive 49 FINANCIAL CONDITION AND 49 B.1 49 True thicknesses 49 Balance Sheet Cash Flow 49 -Lake Andrusia 49 ^ sup #m 49 Trimeris Form 49 Histological 49 Company Periodic Filings 49 hyperintensity 49 yr -1 49 Fig 49 constitutively active 49 LENDER PROCESSING SERVICES INC. 49 δ 49 fusion XRF 49 immunohistochemical analysis 48 titled SUPPLEMENTAL DISCLOSURE 48 Appendices 48 GFP fluorescence 48 WESTWOOD ONE INC. SUPPLEMENTAL 48 platinum Pt 48 transmembrane 48 Å -1 48 Interferometric 48 mesoscopic 48 GASB Issues 48 Corporate Governance Statement 48 Original Bidder Statement 48 acyclic 48 - -Ascaron 48 Raman spectra 48 galactosidase 48 IR spectra 48 substituents 48 diffusivity 48 valence electron 48 periodicities 48 mK 48 surgically resected 48 electron diffraction 48 Gaussian 48 Mineral Resource estimation 48 inhomogeneity 48 www.x cal.com 48 #NE [001] 48 mRNA expression 48 subtotals 48 Supplemental Information 48 hafnium oxide 48 polygenic 48 -Krefeld Germany 48 sine cosine 48 MgO 48 Supplementary Methods 48 Fig. 2d 48 regression coefficients 48 Yb 48 #S #S [003] 48 hamartomas 48 fig. 48 Sgk1 48 Constant Currency 48 Young modulus 48 Non GAAP Disclosures 48 www.corebox.net 48 fig. S6 48 GPa 48 POLYCOM INC. GAAP 48 dimer 48 lamina 48 www.luxottica.com 48 absorption spectroscopy 48 β 48 MINDRAY MEDICAL INTERNATIONAL LIMITED 48 ATTACHMENT 48 Regulation FD Disclosure 48 TRUS 48 Y Zr 48 IFRS IFRS 48 Items Impacting Comparability 48 powder diffraction 48 interphase 48 absorption spectra 48 Income Statement 48 Financial Measures 48 At#g# 48 pseudogap 48 oscillation frequencies 48 electron doped 48 electrons orbiting 48 diffusion coefficient 48 -Peter Van Keuren 48 REGARDING NON GAAP 48 π 48 TEXT OMITTED FROM SOURCE 48 Pro Rata 48 Material Assumptions 48 Fig. 4b 48 Pro Forma Non GAAP 48 USGAAP 48 titanium atoms 48 photomicrograph 48 endonuclease 48 sonographic findings 48 manganite 48 chromitite layers 48 subscript 48 Lorentzian 48 mrad 47 non gaap 47 conductance 47 KaiC 47 WELLS FINANCIAL CORP. 47 intramolecular 47 Adjusted EBITDA Reconciliation 47 T1 weighted 47 Foreign Currency Translation 47 olivines 47 ESO PR 47 TIMP 1 47 Minesite costs 47 annexed hereto 47 σ 47 FINANCIAL SERVICES GUIDE 47 adjusted ebitda 47 tropomyosin 47 rotaxane 47 fibrillar 47 PRO FORMA 47 -hologram stickers 47 unaudited consolidated balance sheet 47 calorimetric 47 subwavelength 47 Cr#O# 47 phospholipase 47 Conversion Ratio 47 Adjusted Diluted EPS 47 Mg Fe 47 azimuthal 47 variogram 47 Logistic Regression 47 rearfoot 47 martensite 47 AuEq g t 47 InAs 47 Drill intercepts 47 tensor 47 Si substrate 47 Measurement Uncertainty 47 supercurrent 47 INV Management Discussion 47 compressional 47 GAAP Adj 47 T2 weighted images 47 RISKS AND UNCERTAINTIES 47 INC. UNAUDITED CONDENSED CONSOLIDATED 47 Supplemental Disclosure 47 cytosolic 47 Income Tax Regs 47 Coulomb blockade 47 interconversion 47 6S RNA 47 photon energies 47 magnetic anisotropy 47 Mantel Haenszel 47 linearized 47 FINANCIAL MEASURES 47 COOH 47 quantum oscillations 47 ultrastructural 47 steric 47 MMLP Annual Report 47 TABLE OF CONTENTS 47 Protein Structures 47 ultrastructure 47 YM BIOSCIENCES INC. 47 variograms 47 Zr 47 Cautionary Information 47 fermion 47 superposed 47 -Adam Bartholomay 47 Repeatability 47 Pro Forma Condensed Consolidated 47 cementite 47 Rab5 47 P2X 47 condensed consolidated balance sheets 47 Cautionary Factors 47 unaudited consolidated interim 47 Cash Flow Margin 47 QDs 47 quantization 47 Code § #-#.# 47 variance ANOVA 47 Condensed consolidated 47 Eur Urol 47 T1 weighted images 47 vibrational modes 47 pentacene 47 Supplemental Data 47 Vps# 47 mu m 47 isomeric 47 Item 9A 47 spectrometric 47 TiO 47 Note Concerning Forward 47 Drill Intersections 47 annexin 47 coiled coil 47 cytochrome c oxidase 47 dynamin 47 #.#c #.#c [006] 47 Confocal microscopy 47 USC § #c 47 Clinical Outcome 47 nonGAAP 47 Mitotic 47 helicity 47 nucleotide sequence 47 #:#-# [002] 47 MWNT 47 wavefunction 47 FIFO EBITDA 47 polypeptide chain 47 metastable 47 Apolipoprotein 47 CICA Handbook 47 NJAC #:#-#.# 47 Fig. 1B 47 -analyst Suki Cooper 47 Non GAAP Financial 47 stromal 47 Frizzled 47 Multivariate 47 Critical Accounting 46 hypointense 46 bivariate 46 electrical resistivity 46 SAXS 46 Contractual Obligations 46 M anagement 46 ultrasonographic 46 -Edgewater Networks 46 methyltransferase 46 Fig. 4c 46 SUPPLEMENTARY INFORMATION 46 LP# LP# 46 χ 46 Topics Covered Executive 46 -Name Directory DND 46 -Meadowbrook Parkway 46 AUDITED 46 RC #.# B [001] 46 Standardized distributable cash 46 Drill Hole Location 46 Proposing Release 46 Disclosure Controls 46 II.#.# 46 APPENDIX 46 http:/www.rohmhaas.com 46 Bragg grating 46 neutron diffraction 46 homodimer 46 REVIEW OF OPERATIONS 46 transferase 46 Nanomechanical 46 F actin 46 Equiv 46 CD# expression [001] 46 w illus 46 #.#-# b [002] 46 unaudited consolidated balance sheets 46 Condensed Consolidated Income 46 kurtosis 46 Core Hand Held 46 beta tubulin 46 attached hereto 46 Haplotype 46 Information Circular dated 46 CFR #.# [002] 46 Normalized Earnings 46 -Cullercoats 46 Distribution Coverage Ratio 46 2μm 46 ssDNA 46 HDG PR# 46 MnO 46 Figure 1A 46 C.1 46 submicrometer 46 α 46 Annexin 46 Average Balances Interest Rates 46 boron atoms 46 colocalization 46 isoprostane 46 enthalpy 46 logistic regressions 46 Financial Instruments Disclosures 46 intraventricular 46 thermodynamic stability 46 Fig.2 46 hnRNP 46 cytochrome b 46 Accori North 46 Variable Interest Entities FIN 46 granitoids 46 undoped 46 indel 46 FRAP 46 Figure 46 dinucleotide 46 MRC# [001] 46 II Item 9A 46 Appendixes 46 MWCNT 46 Memory Legal Footnote 46 oligomeric 46 corresponding reconciliations 46 basaltic rocks 46 Adjusted Non GAAP 46 ileal 46 Histogram 46 Filing Statement dated 46 CFR § #.# [006] 46 Freeport Mcmoran C 46 punctate 46 Amending Directive 46 #N #N 46 unaudited Consolidated Statements 46 antiparallel 46 -Andrea Seabrook 46 superlattices 46 magmatism 46 lysates 46 Invested Capital 46 #/tonne NSR cut 46 SIGNIFICANT ACCOUNTING POLICIES 46 Anomalous radioactivity 46 emitted photons 46 electron pairs 46 CFR § #.# [001] 46 cTnI 46 COOH terminal 46 § #E 46 apparent diffusion coefficient 46 pairwise comparisons 46 nm excitation 46 collagen fibrils 46 Pearson correlation coefficients 46 - -Lucintel 46 FINAL REPORT 46 Western blotting 46 CFR § #.# [004] 46 -# mV [001] 46 icosahedral 46 CdS 46 PER SHARE AMOUNTS 46 Aricheng West 46 ^ sup ^ 46 Fourier transforms 46 Noncritical 46 Interpolation 46 circularly polarized 46 Fig. 2E 46 -Lighting Designers 46 CaM 46 Electron microscopy 46 semaphorin 46 Summary RECONCILIATION OF 46 generalized estimating 46 Pt Pd Au 46 ANNUAL REPORT 46 www.greatpanther.com 46 Roughrider Uranium Deposit 46 Consolidated Condensed Financial 46 CONSOLIDATED SUMMARY OF OPERATIONS 46 Gross Premiums Written 46 SEDAR www.SEDAR.com 46 accompanying condensed consolidated 46 microstructural 46 Compensation Discussion 46 Fig. 1E 46 allele frequency 46 NMR spectra 46 heterojunction 46 INTERIM FINANCIAL STATEMENTS 46 FeO 46 transgene expression 46 ATCF 46 Core Length 46 adatoms 46 Supplementary Prospectus 46 multiplanar 46 metaplasia 46 C.# 46 Consolidated Condensed Statement 46 condensed consolidated 45 histidine 45 GAPDH 45 condensed consolidated financial 45 CONSOLIDATED STATEMENT OF INCOME 45 See USSG § #B#.# 45 carboxy terminal 45 Univariate 45 photolysis 45 crustal thickness 45 aggrecan 45 No. #R Consolidation 45 annexure mark 45 Supplementary Explanatory Memorandum 45 papillary muscle 45 Consolidated Statement 45 EBITDA RECONCILIATION 45 beta gamma 45 fig. S# 45 Kaplan Meier 45 structural lineaments 45 logistic regression model 45 ellipsoid 45 mammalian fatty acid 45 STATE STREET CORPORATION 45 Consolidated Cash Flow 45 Microstructure 45 resonance frequency 45 Statistical Tables 45 WpHG mit dem Ziel 45 N acetyl 45 reconciles GAAP 45 protein phosphatase 45 standardized distributable cash 45 Confocal 45 ligand receptor 45 Secretase 45 sagittal plane 45 Drill composites 45 poly L lysine 45 Adjusted EBITDAS 45 CRE# 45 Normalized EBIT 45 bosonic 45 Anisotropy 45 HERALD #/#/# 45 photoionization 45 keV 45 orbital angular momentum 45 thereof Controls 45 Calculation 45 unaudited condensed 45 dispersive 45 GLOSSARY 45 demodulated 45 Cr Fe 45 USC § #a b 45 USC § #f 45 hyperfine 45 magnesium Mg 45 absorbance 45 isotherm 45 Interval m 45 GaP 45 Linear regression 45 amino acid residues 45 magnetisation 45 Dent Res 45 SEK -#.# -#.# [002] 45 PO4 45 transmembrane domains 45 cosmic ray flux 45 Comparable Basis 45 dipolar 45 Condensed Consolidated Interim 45 #.#nm [002] 45 Mineral Resource Estimation 45 scanning electron microscopy SEM 45 Managed Basis 45 arcsec 45 wireframed 45 histopathologic examination 45 END FOOTNOTE FOOTNOTE 45 U Th 45 SMase 45 EARNINGS AND 45 toroidal 45 retinol binding protein 45 Isotopic 45 apical 45 Fourier transform 45 RecA 45 cathepsin B 45 RISK FACTORS 45 hypoechoic 45 lamellar 45 transvaginal sonography 45 lithographically 45 covariance 45 #S rRNA 45 EOG RESOURCES INC. 45 SMURFIT STONE CONTAINER CORPORATION 45 1μm 45 crackle breccia 45 B.2 45 LUCENT TECHNOLOGIES INC. AND 45 1alpha 45 velocity dispersion 45 NON GAAP FINANCIAL INFORMATION 45 intact parathyroid hormone 45 cm -1 45 actin binding 45 dimensional echocardiography 45 F FDG 45 FINANCIAL INFORMATION 45 missense 45 Maj. Op 45 ^ sup -1 45 morphology 45 MMLP Quarterly Report 45 cm ^ sup 45 www.newsweb.no 45 Fixed Spread 45 datasheet 45 factorial 45 CFR § § #.# [001] 45 www.kla tencor.com 45 #m Tc 45 echogenic 45 Adjusted Basis 45 TO HOLDERS OF 45 computed tomographic scan 45 quasicrystal 45 discriminant analysis 45 Caution Concerning Forward Looking 45 uniaxial 45 micrometer scale 45 EXPLANATORY MEMORANDUM 45 PHOENIX TECHNOLOGIES LTD 45 www.sedar.ca 45 B.3 45 ZrO 2 45 thioredoxin 45 wavefronts 45 adjusted distributable cash 45 trimers 45 operon 45 perovskite 45 caveolae 45 Main Outcome Measures 45 petrological 45 Extension Occurrence 45 Significant Assay Results 45 tetrahedral 45 #S #S [001] 45 Content Outline 45 Looking Statements Except 45 Company Prospectus dated 45 Bulk density 45 FIDELITY NATIONAL INFORMATION SERVICES 45 -Ganga aarti 45 holotype 45 OPERATING EARNINGS LOSS 45 A2 A3 45 depolarization 45 rhyolite tuffs 45 eigenvalue 45 Adjusted Distributable Cash 45 MARTIN MIDSTREAM PARTNERS LP 45 proximal tubule 45 unaudited interim 45 lognormal 45 SEGMENTED INFORMATION 45 confidence intervals CIs 45 Widths 45 ANNEXURE 45 items affecting comparability 45 Restatement 45 III.#.# 45 ASX Announcement 45 #E# [003] 45 cm -3 45 orthologs 45 inhomogeneous 45 multivariable analysis 45 x ray diffraction 45 Qtr Ended 45 REAL ESTATE BUSINESS 45 mT 45 SUMMARY OF QUARTERLY RESULTS 45 Explanatory notes 45 dipole moment 45 Cash Flow Statements 45 proteolysis 45 Introductory teaser rates 45 inhomogeneities 45 proximal femoral 45 annexure marked 45 -tiger muskies 45 Financial Statements 45 polariton 45 Excitation 45 Condensed Consolidated Cash Flow 45 Normalized Payout Ratio 45 Dimensioning 45 Classification Tonnes 45 Interpolated 45 Histopathological 45 www.nap.com 45 intersegment eliminations 45 Reportable Segment 45 Average Balance Sheets 45 quinone 45 anion 45 YEAR ENDED 45 Experimentally 45 backscattered 45 fig. S7 45 pyrope garnets 45 Cth Corporations Act 45 crystallographic 45 striatal 45 FABP 45 -0 Content Outline 45 CRITICAL ACCOUNTING ESTIMATES 45 Fig. 4C 45 CONDENSED CONSOLIDATED INCOME STATEMENTS 45 accompanying Management Discussion 45 IPCC TAR 45 -Kintera GivingFund 45 BP# [003] 45 Financial Ratios 45 immunofluorescence microscopy 45 Phosphorylation 45 micrograph 45 ^ sup 45 Condensed Cash Flow 45 chromatograms 45 MEFs 45 Gaussian distribution 45 synovial 45 vesicle fusion 45 YEAR ENDED DECEMBER 45 EF Tu 44 Cropredy Res 44 Regulation SK 44 HRTEM 44 ROC curves 44 helical 44 AND OTHER SELECTED DATA 44 lithologic 44 HER2 expression 44 financialstatements 44 Supplemental Circular 44 USE OF NON GAAP 44 Extra Ordinary Items 44 anionic 44 follows > 44 coplanar 44 Ferritin 44 cesium atom 44 = Non GAAP [014] 44 paramagnetic 44 BMP receptor 44 Certain comparative 44 Nuveen Nc Div Adv 44 electrophysiologic 44 unrounded 44 GAAP NON GAAP 44 N cadherin 44 Tg mice 44 Retained Earnings Deficit 44 Hysteresis 44 dimeric 44 SWNT 44 dimers 44 Phylogenetic 44 #.#um [001] 44 correlation coefficients 44 Sequential Quarterly 44 thyroglobulin 44 ppm eU 44 perturbation theory 44 unaudited Condensed Consolidated 44 vanadate 44 EGFP 44 G# garnets 44 section #E [004] 44 Equity Investees 44 Adjusted FIFO EBITDA 44 palytoxin 44 trabecular 44 -delegitimation 44 nematic 44 adsorbed 44 sequence homology 44 Figure 1D 44 -Kahaani Ghar Ghar Ki 44 baseline FEV 44 Computed 44 CuO 44 Summarized below 44 longitudinal projection 44 WGS# 44 semiquantitative 44 Mechanistic 44 Location Map 44 Abcourt Mines Inc 44 Fe Mg 44 Scintillometer Readings 44 CFR #.#b 44 Supplemental 44 transmembrane domain 44 Cautionary Notes 44 S#A [001] 44 www.uranerz.com 44 stomatal 44 Pro forma Adjusted EBITDA 44 SIX MONTHS ENDED 44 InSb 44 theSecurities 44 axial length 44 www.duluthmetals.com 44 #,# OH 44 Hall BF Poster 44 S. pombe 44 items impacting comparability 44 sigmoid 44 hexamers 44 arcuate 44 table captioned Reconciliation 44 HERTZ GLOBAL HOLDINGS INC. 44 cantilever deflection 44 T rubrum 44 SPECIAL BUSINESS 44 amino acid residue 44 # [018] 44 -plastisol 44 Wireless Legal Footnote 44 glycosyltransferase 44 shallowly dipping 44 AnnuAl 44 PDZ domain 44 Prospectus dated 44 OF NON GAAP MEASURES 44 molecular orbitals 44 Genotypes 44 Applicability 44 RESULTS OF OPERATIONS 44 acyltransferase 44 Phenotypic 44 ANCOVA 44 #.#-# [020] 44 Pharmacokinetic PK 44 eigenvalues 44 ASC# 44 metaphase 44 Nernst 44 λ 44 L# L# [002] 44 SEMPRA ENERGY Table 44 siderite 44 mitotic spindles 44 Attached hereto